{"Data":[{"Comment":">= 40 - < 50 %","GroupName":"Carcinogenic, mutagenic, reprotoxic (CMR) substances, Category 1A, 1B and 2 under Part 3 Annex VI to EC regulation 1272/2008","GroupNameDisplay":"CMR Substances Europe","SubstanceName":"CYCLOHEXYLAMINE","CasNumber":"108-91-8","Concentration":50.0,"UnitOfMeasure":1,"UomDisplayValue":"%Wt","DeclareAnotherSubstance":null,"Id":"8c1a199f-e3d2-4167-9a3f-4aa1768675a2","GroupQuestionIdentifier":"Q3001Carcinogenic","ConcentrationOperator":0,"ConcentrationOperatorDisplayValue":" "},{"Comment":">= 20 - < 30 %","GroupName":"Corrosive/Irritating substances as listed in Cat 1&2 Reg 1272/2008","GroupNameDisplay":"Corrosive/Irritating Substances","SubstanceName":"2-diethylaminoethanol","CasNumber":"100-37-8","Concentration":30.0,"UnitOfMeasure":1,"UomDisplayValue":"%Wt","DeclareAnotherSubstance":null,"Id":"22a2bb7b-1ba4-423e-a9ec-66b3c48f55d5","GroupQuestionIdentifier":"Q3001CorrosiveSubstances","ConcentrationOperator":0,"ConcentrationOperatorDisplayValue":" "},{"Comment":">= 15 - < 20 %","GroupName":"Corrosive/Irritating substances as listed in Cat 1&2 Reg 1272/2008","GroupNameDisplay":"Corrosive/Irritating Substances","SubstanceName":"Morpholine","CasNumber":"110-91-8","Concentration":20.0,"UnitOfMeasure":1,"UomDisplayValue":"%Wt","DeclareAnotherSubstance":null,"Id":"d7a448cc-499b-4811-b636-5042145405bd","GroupQuestionIdentifier":"Q3001CorrosiveSubstances","ConcentrationOperator":0,"ConcentrationOperatorDisplayValue":" "},{"Comment":"< 0.1","GroupName":"Endocrine disruptors as listed in Reg 2017/745 Annex I, 10.4.1 (b)","GroupNameDisplay":"Endocrine Disruptors","SubstanceName":"ETHYLENE GLYCOL MONOMETHYL ETHER","CasNumber":"109-86-4","Concentration":0.1,"UnitOfMeasure":1,"UomDisplayValue":"%Wt","DeclareAnotherSubstance":null,"Id":"8637ff67-7728-42e6-bf0d-ff9f51c4b158","GroupQuestionIdentifier":"Q3001SubGrp19","ConcentrationOperator":0,"ConcentrationOperatorDisplayValue":" "},{"Comment":"< 0.005 % as impurity","GroupName":"Endocrine disruptors as listed in Reg 2017/745 Annex I, 10.4.1 (b)","GroupNameDisplay":"Endocrine Disruptors","SubstanceName":"BENZENE","CasNumber":"71-43-2","Concentration":0.005,"UnitOfMeasure":1,"UomDisplayValue":"%Wt","DeclareAnotherSubstance":null,"Id":"ec86a420-000a-4d2f-b3a8-5e76774c640b","GroupQuestionIdentifier":"Q3001SubGrp19","ConcentrationOperator":0,"ConcentrationOperatorDisplayValue":" "},{"Comment":"< 0.005 % as impurity","GroupName":"Endocrine disruptors as listed in Reg 2017/745 Annex I, 10.4.1 (b)","GroupNameDisplay":"Endocrine Disruptors","SubstanceName":"ANILINE","CasNumber":"62-53-3","Concentration":0.005,"UnitOfMeasure":1,"UomDisplayValue":"%Wt","DeclareAnotherSubstance":null,"Id":"6a9273fb-5feb-4f85-a387-7d054fa66ce9","GroupQuestionIdentifier":"Q3001SubGrp19","ConcentrationOperator":0,"ConcentrationOperatorDisplayValue":" "},{"Comment":"< 0.1 % as impurity","GroupName":"Endocrine disruptors as listed in Reg 2017/745 Annex I, 10.4.1 (b)","GroupNameDisplay":"Endocrine Disruptors","SubstanceName":"ETHYLENE GLYCOL MONOMETHYL ETHER","CasNumber":"109-86-4","Concentration":0.1,"UnitOfMeasure":1,"UomDisplayValue":"%Wt","DeclareAnotherSubstance":null,"Id":"3cb918d4-213d-43d5-bfc4-eb19cdcd237f","GroupQuestionIdentifier":"Q3001SubGrp19","ConcentrationOperator":0,"ConcentrationOperatorDisplayValue":" "}],"Total":7,"AggregateResults":null,"Errors":null}